KA
Price:
$0.659
Market Cap:
$8.08M
Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.[Read more]
Industry
Biotechnology
IPO Date
2016-02-11
Stock Exchange
NASDAQ
Ticker
KA
According to Kineta, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.14. This represents a change of -75.01% compared to the average of 0.57 of the last 4 quarters.
The mean historical Current Ratio of Kineta, Inc. over the last ten years is 4.92. The current 0.14 Current Ratio has changed 188.53% with respect to the historical average. Over the past ten years (40 quarters), KA's Current Ratio was at its highest in in the September 2020 quarter at 6.76. The Current Ratio was at its lowest in in the June 2024 quarter at 0.14.
Average
4.92
Median
1.52
Minimum
0.78
Maximum
14.05
Discovering the peaks and valleys of Kineta, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 578.56%
Maximum Annual Current Ratio = 14.05
Minimum Annual Increase = -85.94%
Minimum Annual Current Ratio = 0.78
Year | Current Ratio | Change |
---|---|---|
2023 | 0.85 | -28.61% |
2022 | 1.18 | 51.76% |
2021 | 0.78 | -19.34% |
2020 | 0.97 | -85.94% |
2019 | 6.88 | -51.03% |
2018 | 14.05 | 82.45% |
2017 | 7.70 | -25.28% |
2016 | 10.31 | 578.56% |
The current Current Ratio of Kineta, Inc. (KA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.94
5-year avg
2.13
10-year avg
4.92
Kineta, Inc.’s Current Ratio is less than Rezolute, Inc. (11.82), less than Cyteir Therapeutics, Inc. (21.89), less than XOMA Corporation (8.71), less than Protagenic Therapeutics, Inc. (2.03), less than Tempest Therapeutics, Inc. (2.17), less than Candel Therapeutics, Inc. (1.62), less than MiNK Therapeutics, Inc. (0.93), less than Forte Biosciences, Inc. (2.82), less than AlloVir, Inc. (55.08), less than Dyadic International, Inc. (5.39), less than DiaMedica Therapeutics Inc. (17.82), less than Kintara Therapeutics, Inc. (5.04), less than Silo Pharma, Inc. (5.84), less than Protagenic Therapeutics, Inc. (2.03), less than Lumos Pharma, Inc. (4.23), less than Anebulo Pharmaceuticals, Inc. (5.32), less than Molecular Partners AG (14.58), less than Mineralys Therapeutics, Inc. (11.20), less than AN2 Therapeutics, Inc. (10.61), less than Pharvaris N.V. (18.45), less than PepGen Inc. (7.45),
Company | Current Ratio | Market cap |
---|---|---|
11.82 | $240.80M | |
21.89 | $108.71M | |
8.71 | $332.97M | |
2.03 | $3.37M | |
2.17 | $31.26M | |
1.62 | $197.00M | |
0.93 | $31.17M | |
2.82 | $11.11M | |
55.08 | $88.16M | |
5.39 | $37.14M | |
17.82 | $172.27M | |
5.04 | $9.63M | |
5.84 | $5.37M | |
2.03 | $2.69M | |
4.23 | $30.87M | |
5.32 | $46.68M | |
14.58 | $182.90M | |
11.20 | $558.43M | |
10.61 | $30.44M | |
18.45 | $1.03B | |
7.45 | $287.77M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kineta, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kineta, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Kineta, Inc.'s Current Ratio?
How is the Current Ratio calculated for Kineta, Inc. (KA)?
What is the highest Current Ratio for Kineta, Inc. (KA)?
What is the 3-year average Current Ratio for Kineta, Inc. (KA)?
What is the 5-year average Current Ratio for Kineta, Inc. (KA)?
How does the current Current Ratio for Kineta, Inc. (KA) compare to its historical average?